Astec LifeSciences Limited — Board Meeting, 28-07-2025: Outcome of Board Meeting

Astec LifeSciences' board met to approve the financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of Rs 91.08 Cr, up from Rs 69.37 Cr in the same quarter last year. While revenue saw growth, the company posted a consolidated net loss of Rs 33.03 Cr, an improvement compared to the Rs 39.72 Cr loss in the prior year's comparable quarter. The board also noted the ongoing Rs 249.35 Cr Rights Issue, which concluded today, a key step to bolster the company's financial position.